DNI Logo2018 Full Color current research text box

Principle Investigators: Dr. Lixin ZhangZhang edited for website

Disease: Ménière’s disease

Research Description: Ménière’s disease (MD) is a chronic inner ear condition, with symptoms including vertigo, dizziness, loss of balance, tinnitus and ear pressure. In addition, most patients will experience some degree of permanent hearing loss. While there are a limited number of disease-modifying treatments, there is no FDA-approved treatment for MD. Previous pilot research by Dr. Zhang has shown that anti-epilepsy medications can help reduce vertigo in MD patients. Anti-anxiety medicines have also been shown to help treat chronic subjective dizziness, which is related to underlying anxiety and common in patients with MD. Anxiety can be a contributing factor to trigger MD vertigo attacks. The proposed project will combine repurposed anti-epilepsy and anti-anxiety oral drugs to determine if the combination can further reduce MD symptoms and improve quality of life, while also collecting data on any potential impact of the drug combination on progressive inner ear damage and hearing loss.

CWR Funding Role: Primary funder

CWR Funding Partner: Anonymous

Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*

*required

If the link above doesn't work, please contact our Admin support at admin@cureswithinreach.org with your Full Name and Email Address to sign up!

 

Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

info@cureswithinreach.org

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.

 

Monday the 16th. Copyright 2018 Cures Within Reach.